Baker Ellis Asset Management »

Allovir shares owned by Baker Ellis Asset Management

Quarter-by-quarter ownership of Allovir (ALVR) shares owned by Baker Ellis Asset Management from 13F filings

Historical chart of Baker Ellis Asset Management investment in Allovir

Tip: Access up to 7 years of quarterly data

All positions including Allovir held by Baker Ellis Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Allovir by Baker Ellis Asset Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $6.8k 10k 0.68

More positions owned by Baker Ellis Asset Management

Vanguard Index Fds Total Stk Mkt (VTI)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Microsoft Corporation (MSFT)
Vanguard Whitehall Fds High Div Yld (VYM)
Vanguard World Inf Tech Etf (VGT)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Lam Research Corporation (LRCX)
Encore Wire Corporation (WIRE)
John Hancock Exchange Traded Multifactor Mi (JHMM)
Invesco Exchange Traded Fd T Ftse Rafi 1000 (PRF)
Fidelity Merrimack Str Tr Total Bd Etf (FBND)
Goldman Sachs Etf Tr Acces Treasury (GBIL)
Schwab Strategic Tr Us Dividend Eq (SCHD)
Goldman Sachs Etf Tr Activebeta Int (GSIE)
JPMorgan Chase & Co. (JPM)

View all positions for Baker Ellis Asset Management

Top funds holding Allovir

Artal Group
Millennium Management
Vanguard Group
Redmile Group
American International
Charles Schwab Investment Management
Goldman Sachs Group
Jpmorgan Chase & Co
Marshall Wace
Squarepoint Ops
Citadel Advisors
Two Sigma Investments
D. E. Shaw & Co
GSA Capital Partners
Commonwealth Equity Services

View all funds holding Allovir